Molecular basis of insulin resistance.
The recent application of recombinant DNA technology to clinical investigation now allows the identification of the molecular alterations responsible for insulin resistance. In this review, the recent knowledge concerning these investigations is reported. Genetic mutations of the insulin gene as the source of insulin resistance have been reported for a long time. More recently a series of mutations of the insulin receptor gene have been identified as the cause of the extreme insulin resistance, observed in rare syndromes, such as type A insulin resistance or leprechaunism. However, it is probable that the majority of the molecular defects causing insulin resistance occur at the postreceptor level. The key proteins involved in the different intracellular signalling pathways of insulin are only partly identified. A better understanding of the mechanisms of insulin action is essential for the identification of corresponding genetic alterations. The investigations concerning the glucose transporter GLUT4 and glucokinase genes are good examples of complex but promising research, which has recently started. Elucidation of the genetic and molecular basis of diseases such as type II diabetes or other states associated with insulin resistance, is the long-term goal.
Clauser
E
E
INSERM U36, Collège de France, Paris, France.
Leconte
I
I
Auzan
C
C
D051275:Glucose Transporter Type 4; D006801:Humans; D007328:Insulin / Q000235:genetics* / Q000494:pharmacology; D007333:Insulin Resistance / Q000235:genetics*; D009004:Monosaccharide Transport Proteins / Q000235:genetics; D009124:Muscle Proteins; D009154:Mutation; D011972:Receptor, Insulin / Q000235:genetics
D051275:Glucose Transporter Type 4; D007328:Insulin; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; C495692:SLC2A4 protein, human; D011972:Receptor, Insulin